Vildagliptin is a powerful oral antidiabetic medicine classified as a DPP-4 (dipeptidyl peptidase-4) inhibitor, widely used to manage Type 2 Diabetes Mellitus. It helps maintain stable blood glucose levels, especially after meals, without significant risk of weight gain or hypoglycemia.
Amber Lifesciences is a trusted pharmaceutical manufacturer and exporter of high-quality Vildagliptin formulations, serving global markets with WHO-GMP-certified production standards. We ensure a reliable supply to every corner of the world.
How Vildagliptin Works: Targeting Blood Sugar at Its Root
The mechanism behind Vildagliptin is both innovative and precise:
- It inhibits the DPP-4 enzyme, which prevents the breakdown of incretin hormones (GLP-1 and GIP).
- These incretins increase insulin release in response to high blood glucose and decrease glucagon secretion.
- This dual action helps lower both fasting and post-meal blood sugar without causing blood sugar crashes.
Dosing and Usage Guidelines of Vildagliptin
It is typically available as a 50 mg tablet and can be taken:
- Once or twice daily, depending on the treatment plan.
- Alone or in combination with other antidiabetic drugs like metformin, sulfonylureas, or thiazolidinediones.
- With or without food, offering convenience and flexibility.
Vildagliptin Available Formulations and Combinations
It is often found under brand names like Galvus® or GalvusMet® when combined with metformin. Common combinations include:
- Vildagliptin 50 mg + Metformin 500 mg
- Vildagliptin 50 mg + Metformin 850 mg
- Vildagliptin 50 mg + Metformin 1000 mg
These combinations help enhance glycemic control for patients who need dual therapy.
Why Choose Vildagliptin?
Here are the standout benefits:
- Weight-neutral – Unlike many diabetes drugs, it doesn’t cause weight gain.
- Low hypoglycemia risk – Especially when not combined with insulin or sulfonylureas.
- Effective in renal impairment – Safe for mild to moderate kidney issues (with adjustments).
- Reduces HbA1c levels by approximately 0.5–1% – Backed by clinical studies.
Vildagliptin Safety Profile and Side Effects
It is usually well-tolerated; however, like other medicines, it can sometimes lead to:
- Headache
- Dizziness
- Mild digestive discomfort
- Rare cases of pancreatitis or liver enzyme elevation
Tip: Routine liver function monitoring is advised, especially for long-term users.
Who Should Avoid Vildagliptin?
- Patients with Type 1 diabetes
- Those with diabetic ketoacidosis
- Individuals with severe liver disease
- Those on dialysis (CrCl < 30 mL/min)
Export Quality Vildagliptin from India – Amber Lifesciences
Amber Lifesciences Pvt. Ltd. is a trusted pharmaceutical manufacturer and exporter of high-quality Vildagliptin APIs and formulations. With state-of-the-art WHO-GMP, USFDA, and EU-GMP certified facilities, we ensure:
- Global-standard quality
- Regulatory compliance for LATAM, Africa, Asia & EU markets
- Timely bulk API delivery and contract manufacturing
Looking for a reliable Vildagliptin supplier from India? Partner with Amber Lifesciences today.
Conclusion
Vildagliptin is an ideal choice for patients needing better post-meal glucose control with minimal risk of weight gain or hypoglycemia. Its versatile use in mono or combination therapy makes it a valuable part of modern diabetes care.
For bulk orders or to buy Vildagliptin from a reliable Indian exporter, contact Amber Lifesciences Pvt Ltd – your trusted source for high-quality, GMP-certified antidiabetic medications.
